|
Feb 18
|
Vertex to Participate in Upcoming March Investor Conferences
|
|
Feb 17
|
3 Stocks That Could Trounce the Market in 2025
|
|
Feb 15
|
2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025
|
|
Feb 14
|
CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99
|
|
Feb 14
|
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Feb 14
|
The Ultimate Healthcare Stock to Buy With $500 Right Now
|
|
Feb 14
|
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
|
|
Feb 12
|
Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank
|
|
Feb 12
|
Vertex Pharmaceuticals price target raised to $520 from $460 at Truist
|
|
Feb 12
|
CRISPR Therapeutics Q4 Earnings and Revenues Surpass Estimates
|
|
Feb 11
|
Vertex Posts 'Another Impressive Quarterly Revenue Beat.' But The Future Remains Uncertain.
|
|
Feb 11
|
VRTX's Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales
|
|
Feb 11
|
Vertex: Strong Sales, Stronger Pipeline
|
|
Feb 11
|
Q4 2024 Vertex Pharmaceuticals Inc Earnings Call
|
|
Feb 11
|
Vertex Pharmaceuticals Inc (VRTX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 11
|
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
|
|
Feb 10
|
Vertex Pharmaceuticals (VRTX) Misses Q4 Earnings Estimates
|
|
Feb 10
|
Vertex Pharmaceuticals' Revenue Forecast Tops Expectations
|
|
Feb 10
|
Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 Sales Top Estimates
|
|
Feb 10
|
Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand
|